Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosis
- 1 April 1988
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 112 (4) , 547-554
- https://doi.org/10.1016/s0022-3476(88)80165-3
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Granulocyte elastase-α1-antiproteinase complex in cystic fibrosis: Sensitive plasma assay for monitoring pulmonary infectionsThe Journal of Pediatrics, 1987
- Selective media for the quantitation of bacteria in cystic fibrosis sputumJournal of Medical Microbiology, 1984
- The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosisThe Journal of Pediatrics, 1981
- Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis?The Journal of Pediatrics, 1980
- Pus, deoxyribonucleic acid, and sputum viscosity.Thorax, 1978
- Treatment of pulmonary infections in patients with cystic fibrosis: A comparative study of ticarcillin and gentamicinThe Journal of Pediatrics, 1977
- Tobramycin and Ticarcillin Therapy for Exacerbations of Pulmonary Disease in Patients with Cystic FibrosisThe Journal of Infectious Diseases, 1976
- A new prognostic score and clinical evaluation system for cystic fibrosisThe Journal of Pediatrics, 1973
- New objective criteria for inflammation in bronchial secretions.BMJ, 1968
- SPUTUM EXAMINATION AND THE INVESTIGATION OF " CHRONIC BRONCHITIS "The Lancet, 1959